Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE).

SDHB genetic paraganglioma pediatric pheochromocytoma

Journal

Journal of the Endocrine Society
ISSN: 2472-1972
Titre abrégé: J Endocr Soc
Pays: United States
ID NLM: 101697997

Informations de publication

Date de publication:
01 May 2020
Historique:
received: 25 08 2019
accepted: 01 04 2020
entrez: 21 5 2020
pubmed: 21 5 2020
medline: 21 5 2020
Statut: epublish

Résumé

The purpose of this work is to assess the clinical outcome of pediatric patients diagnosed with pheochromocytoma and paraganglioma (PPGL) detected in France since 2000. A retrospective multicenter study was conducted that included all patients younger than 18 years with PPGL diagnosed in France between 2000 and 2016. Patients were identified from 4 different sources: the National Registry of Childhood Solid Tumors, the French Pediatric Rare Tumors Database, the French registry of succinate dehydrogenase (SDH)-related hereditary paraganglioma, and the nationwide TenGen network. Among 113 eligible patients, 81 children with available data were enrolled (41 with adrenal and 40 with extra-adrenal PPGL). At diagnosis, 11 had synchronous metastases. After a median follow-up of 53 months, 27 patients experienced a new event (n = 7 second PPGL, n = 1 second paraganglioma [PGL], n = 8 local recurrences, n = 10 metastatic relapses, n = 1 new tumor) and 2 patients died of their disease. The 3- and 10-year event-free survival rates were 80% (71%-90%) and 39% (20%-57%),respectively, whereas the overall survival rate was 97% (93%-100%)at 3 and 10 years. A germline mutation in one PPGL-susceptibility gene was identified in 53 of the 68 (77%) patients who underwent genetic testing ( Most pediatric PPGLs are associated with germline mutations and require specific follow-up because of the high risk of tumor recurrence.

Identifiants

pubmed: 32432211
doi: 10.1210/jendso/bvaa039
pii: bvaa039
pmc: PMC7217277
doi:

Types de publication

Journal Article

Langues

eng

Pagination

bvaa039

Informations de copyright

© Endocrine Society 2020.

Références

Indian Pediatr. 2014 Apr;51(4):299-302
pubmed: 24825268
Am Surg. 2000 Dec;66(12):1085-91; discussion 1092
pubmed: 11149577
Surgery. 2017 Jan;161(1):220-227
pubmed: 27865588
Hum Mol Genet. 2010 Aug 1;19(15):3011-20
pubmed: 20484225
N Engl J Med. 2002 May 9;346(19):1459-66
pubmed: 12000816
J Intern Med. 2016 Dec;280(6):559-573
pubmed: 27165774
Cancer Res. 2003 Sep 1;63(17):5615-21
pubmed: 14500403
Ann N Y Acad Sci. 2006 Aug;1073:166-76
pubmed: 17102083
Eur J Endocrinol. 2016 May;174(5):G1-G10
pubmed: 27048283
Cancer Genet. 2012 Jan-Feb;205(1-2):1-11
pubmed: 22429592
Can Urol Assoc J. 2017 May;11(5):E240-E243
pubmed: 28503241
Endocr Connect. 2013 May 28;2(2):104-11
pubmed: 23781326
Hum Pathol. 1990 Nov;21(11):1168-80
pubmed: 2172151
J Clin Endocrinol Metab. 2009 May;94(5):1541-7
pubmed: 19223516
Clin Pediatr (Phila). 2005 Oct;44(8):715-9
pubmed: 16211197
Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):92-102
pubmed: 17237836
J Pediatr. 1963 Aug;63:314-30
pubmed: 14046640
Indian J Pediatr. 2009 Nov;76(11):1151-3
pubmed: 20072855
Endocr Relat Cancer. 2013 Dec 16;21(1):17-25
pubmed: 24169644
Horm Metab Res. 2012 May;44(5):390-9
pubmed: 22314389
J Pediatr Endocrinol Metab. 2006 May;19(5):749-56
pubmed: 16789642
Nat Rev Cancer. 2014 Feb;14(2):108-19
pubmed: 24442145
Clin Endocrinol (Oxf). 2017 Feb;86(2):286-296
pubmed: 27678251
J Pediatr Surg. 1983 Dec;18(6):879-84
pubmed: 6141233
J Pediatr Surg. 1990 Oct;25(10):1063-5
pubmed: 2262859
Klin Padiatr. 2012 Oct;224(6):416-20
pubmed: 23143769
Endocr Pract. 2016 Mar;22(3):302-14
pubmed: 26523625
Endocr Relat Cancer. 2013 May 30;20(3):L1-6
pubmed: 23404858
J Clin Endocrinol Metab. 2017 Apr 1;102(4):1122-1132
pubmed: 28324046
Thyroid. 2017 Oct;27(10):1332-1334
pubmed: 28747092
Lancet Oncol. 2010 Apr;11(4):366-72
pubmed: 20071235
Clin Cancer Res. 2017 Jun 15;23(12):e68-e75
pubmed: 28620007
J Oncol. 2012;2012:872713
pubmed: 22851969
J Pediatr Surg. 2001 Mar;36(3):447-52
pubmed: 11226993
Nat Rev Endocrinol. 2015 Feb;11(2):101-11
pubmed: 25385035
Ann N Y Acad Sci. 2006 Aug;1073:30-7
pubmed: 17102069
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42
pubmed: 24893135
Pediatrics. 2006 Sep;118(3):1109-17
pubmed: 16951005
Nat Genet. 2010 Mar;42(3):229-33
pubmed: 20154675
J Clin Oncol. 2011 Nov 1;29(31):4137-42
pubmed: 21969497
JAMA. 2004 Aug 25;292(8):943-51
pubmed: 15328326

Auteurs

Marie de Tersant (M)

Centre de Cancérologie Gustave Roussy, Département de Cancérologie de l'Enfant et de l'Adolescent, Paris-Saclay University Villejuif, France.

Lucile Généré (L)

Institut d'Hématologie et d'oncologie pédiatrique, Lyon, France.

Claire Freyçon (C)

Centre Hospitalier Universitaire Grenoble Alpes, Immuno-hémato-oncologie pédiatrique, La Tronche, France.

Sophie Villebasse (S)

Centre de Cancérologie Gustave Roussy, Département de Cancérologie de l'Enfant et de l'Adolescent, Paris-Saclay University Villejuif, France.

Rachid Abbas (R)

Centre de Cancérologie Gustave Roussy, Service de Biostatistique et d'Epidémiologie, Paris-Saclay University Villejuif, France.

Anne Barlier (A)

Aix Marseille Université, APHM, INSERM, MMG, Laboratory of Molecular Biology Hospital La Conception, Marseille Cedex 5, France.

Damien Bodet (D)

CHU de Caen, Hémato- Immuno-Oncologie Pédiatrique, Caen, France.

Nadège Corradini (N)

Institut d'Hématologie et d'oncologie pédiatrique, Lyon, France.

Anne-Sophie Defachelles (AS)

Centre Oscar Lambert, Unité d'Oncologie Pédiatrique, Lille, France.

Natacha Entz-Werle (N)

Hôpitaux Universitaire de Strasbourg, Onco-Hématologie Pédiatrique, Strasbourg, France.

Cyrielle Fouquet (C)

Groupe Hospitalier Pellegrin, Unité d'Oncologie et Hématologie Pédiatriques, Bordeaux, France.

Louise Galmiche (L)

Assistance Publique Hôpitaux de Paris, Hôpital Necker Enfants Malades, Anatomie Pathologique, Paris, France.

Virginie Gandemer (V)

Hôpital Sud, CHU de Rennes, Hémato-Oncologie Pédiatrique, Rennes, France.

Brigitte Lacour (B)

Registre National des Tumeurs Solides de l'Enfant, CHU de Nancy, 54500 Vandoeuvre-Lès-Nancy, France; Inserm U1153, Centre de Recherche Epidémiolgie et StatistiqueS (CRESS), Université de Paris, Equipe d'Epidemiologie des cancers de l'enfant et de l'adolescent (EPICEA), Paris, France.

Ludovic Mansuy (L)

CHU de Nancy-Hôpital de Brabois, Service d'hémato-oncologie pédiatrique, Vandoeuvre-lès-Nancy Cedex, France.

Daniel Orbach (D)

SIREDO Oncology Center (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, Université PSL Paris, France, Paris, France.
Comité FRACTURE des tumeurs très rares pédiatriques de la SFCE.

Claire Pluchart (C)

CHU de Reims, Hémato-Oncologie Pédiatrique, Reims, France.

Yves Réguerre (Y)

CHU de Saint Denis, Service d'Oncologie et d'hématologie pédiatrique, La Réunion, France.

Charlotte Rigaud (C)

Centre de Cancérologie Gustave Roussy, Département de Cancérologie de l'Enfant et de l'Adolescent, Paris-Saclay University Villejuif, France.

Sabine Sarnacki (S)

Assistance Publique Hôpitaux de Paris, Hôpital Necker Enfants Malades, Chirurgie Pédiatrique, Paris, France.

Nicolas Sirvent (N)

CHU de Montpellier, Onco-Hématologie Pédiatrique, Montpellier, France.

Jean-Louis Stephan (JL)

CHU de Saint-Etienne, Hématologie et Oncologie Pédiatrique, Hôpital Nord, Saint-Priest-en-Jarez, France.

Estelle Thebaud (E)

CHU de Nantes, Hématologie et Oncologie Pédiatrique, Nantes, France.

Anne-Paule Gimenez-Roqueplo (AP)

Université de Paris, PARCC, INSERM, Paris, France.
Service de Génétique, AP-HP, Hôpital Européen Georges Pompidou, Paris, France.

Laurence Brugières (L)

Centre de Cancérologie Gustave Roussy, Département de Cancérologie de l'Enfant et de l'Adolescent, Paris-Saclay University Villejuif, France.

Classifications MeSH